NYSE ARCA | ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index.
The underlying index measures the performance of the pharmaceuticals sector of theU. S. equity market.
The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 21.56% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 19.80% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 5.59% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 5.29% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.41% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.23% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 4.13% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.06% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.05% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 3.36% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 3.14% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 2.47% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 2.13% |
| PBH | Prestige Brand Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.69% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 1.63% |
| PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 1.55% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 1.50% |
| CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 1.39% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 0.88% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 0.82% |